Skip to main content

Free Content Correspondence

Download Article:
(PDF 147.1865234375 kb)


Utility of fluoroquinolones in multidrug-resistant tuberculosis (MDR-TB)—a balanced view? W. W. Yew, C. H. Chau, Tuberculosis & Chest Unit, Grantham Hospital, 125 Wong Chuk Hang Road, Aberdeen, Hong Kong, China

In reply. Thelma E. Tupasi, MD, Tropical Disease Foundation, Makati Medical Center, Makati 1200, Philippines

In reply. Rupak Singla, Sanjay Gupta, Rajnish Gupta, V. K. Arora, L.R.S. Institute of TB and Allied Diseases, Sri Aurobindo Marg, New Delhi, 110030 India

Periodic or routine susceptibility testing in tuberculosis control. Andreas Kalk, Medical Advisor, German Leprosy Relief Association, Wuerzburg, Germany

In reply. Armand Van Deun, Mycobacteriology Unit, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerpen, Belgium

Document Type: Letter Paper

Publication date: 2002-02-01

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more